欢迎来到天天文库
浏览记录
ID:36772680
大小:1.90 MB
页数:48页
时间:2019-05-15
《复胃散治疗慢性萎缩性胃炎的临床研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、复胃散治疗慢性萎缩性胃炎的临床研究,lli/./ili/i.i/ili,lilill。liilii/lilliiullill3illlil4ilii//i中文摘要目的本研究旨在从临床方面观察复胃散治疗慢性萎缩性胃炎癌前病变的疗效并探讨其可能的作用机理,为临床新药研究提供理论依据。方法取泰山医学院附属医院门诊胃镜确诊为CAG的患者60例,随机分为治疗组30例,对照组30例,两组在性别、年龄、病理、HP感染方面均无明显差异(P>0.05)。治疗组予以自拟复胃散治疗,每次99,每日2次,3个月为一疗程,
2、治疗1—2个疗程。对照组予以奥美拉唑(Omeprazole)10mg,每日2次;果胶铋100mg,每日3次。1个月为一疗程,治疗1.2个疗程。主要观察两组患者服药前后主要症状改善情况,胃镜及病理组织学变化情况及HP清除情况。结果治疗组、对照组治疗CAG的临床总有效率分别为86.67%和63.33%,两组间临床疗效有显著差异(p<0.05);两组胃镜有效率分别为93.33%和73.33%,两组治疗后胃镜结果对比有显著性差异(p3、治疗后腺体萎缩情况对比有显著性差异(p<0.05);两组肠上皮化生和不典型增生治疗有效率分别为86.95%、59.09%,两组治疗后肠上皮化生和不典型增生改善情况对比有显著性差异(p<0.05);两组HP感染治疗有效率分别为62.96%、56.00%,两组治疗后HP感染清除方面对比无显著性差异(p>0.05)。结论复胃散可明显改善患者的临床症状,提高患者的生活质量;复胃散对患者胃黏膜镜下改变,病理改变(肠上皮化生、不典型增生)有一定的逆转作用;复胃散有一定的抗HP感染、抗炎作用;复胃散在临床应用中4、未发现明显毒副作用。关键词复胃散;慢性萎缩性胃炎;幽门螺杆菌lSTUDY0NTHECURATIVEEFFECTSOFCHRONICATROPHICGASTRITISPATIENTSTREATEDBY“FUWEISAN"Major:GeriatricsPostgraduate:YidongQinTutor:Prof.JiangongHuABSTRACTubjectiveToinvestigatetheeffectsandmechanismofFuweisanonpatientswhohadPre—c5、ancerlesionsofchronicatrophicgastritis(CAG),inordertOsupplytheorybasesforextendingnewclinicalmedicine.Methods60CAGPatientswererandomlydividedintotwogroups,onegroup(30patients)wastreatedbyfunweisan,thecontrolgroupwastreatedbyOmeprazole.Therewerenosigni6、ficantdifferenceinsex,age,symptoms,HPinfectionrateandpathologicalchangesbetweentwogroups.Threemonthsisonecourseoftreatment,andthepatientsweretreatedtwocourses.ReSUItsTheremedyresultshows:FuweisangotobviouscurativeeffectintreatingCAG,totalefficacyratew7、as86.67%,thecontrolgroupwas63.33%(P<0.05).TheeradicationrateofHPwas62.96%,whiletheotheronewas56.00%(P>0.05).Therewasasignificantdifferenceinimprovingthepathologicalchangeofatrophy,IMbetweentwogroups,butnosignificantoneinimprovingDys.ConclusionFuweisan8、isbetterthanOmeprazoleinimprovingclinicalsymptoms,livingqualityofCAGpatientsobviously.AndFuweisanisobviouslyreversegastro—scopeandhistologyofCAGpatients.KeywordsFuweisan;ChronicAtrophicGastritis;HelicobacterPylori,英文缩写英文全称符号说明中文全称CAGChronic’At
3、治疗后腺体萎缩情况对比有显著性差异(p<0.05);两组肠上皮化生和不典型增生治疗有效率分别为86.95%、59.09%,两组治疗后肠上皮化生和不典型增生改善情况对比有显著性差异(p<0.05);两组HP感染治疗有效率分别为62.96%、56.00%,两组治疗后HP感染清除方面对比无显著性差异(p>0.05)。结论复胃散可明显改善患者的临床症状,提高患者的生活质量;复胃散对患者胃黏膜镜下改变,病理改变(肠上皮化生、不典型增生)有一定的逆转作用;复胃散有一定的抗HP感染、抗炎作用;复胃散在临床应用中
4、未发现明显毒副作用。关键词复胃散;慢性萎缩性胃炎;幽门螺杆菌lSTUDY0NTHECURATIVEEFFECTSOFCHRONICATROPHICGASTRITISPATIENTSTREATEDBY“FUWEISAN"Major:GeriatricsPostgraduate:YidongQinTutor:Prof.JiangongHuABSTRACTubjectiveToinvestigatetheeffectsandmechanismofFuweisanonpatientswhohadPre—c
5、ancerlesionsofchronicatrophicgastritis(CAG),inordertOsupplytheorybasesforextendingnewclinicalmedicine.Methods60CAGPatientswererandomlydividedintotwogroups,onegroup(30patients)wastreatedbyfunweisan,thecontrolgroupwastreatedbyOmeprazole.Therewerenosigni
6、ficantdifferenceinsex,age,symptoms,HPinfectionrateandpathologicalchangesbetweentwogroups.Threemonthsisonecourseoftreatment,andthepatientsweretreatedtwocourses.ReSUItsTheremedyresultshows:FuweisangotobviouscurativeeffectintreatingCAG,totalefficacyratew
7、as86.67%,thecontrolgroupwas63.33%(P<0.05).TheeradicationrateofHPwas62.96%,whiletheotheronewas56.00%(P>0.05).Therewasasignificantdifferenceinimprovingthepathologicalchangeofatrophy,IMbetweentwogroups,butnosignificantoneinimprovingDys.ConclusionFuweisan
8、isbetterthanOmeprazoleinimprovingclinicalsymptoms,livingqualityofCAGpatientsobviously.AndFuweisanisobviouslyreversegastro—scopeandhistologyofCAGpatients.KeywordsFuweisan;ChronicAtrophicGastritis;HelicobacterPylori,英文缩写英文全称符号说明中文全称CAGChronic’At
此文档下载收益归作者所有